Drugs / BCWP_C003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01992211 | Dec 2016 → Apr 2017 | — | BC World Pharm Co. Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCWP_C003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01992211 ↗ |
| Route | Oral | “Participant will be administered a single oral dose of BCWP\_C003 under Fasting condition or Fed condition according to sequence.” NCT01992211 ↗ |